BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29156377)

  • 21. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene mutations in a Han Chinese Alzheimer's disease cohort.
    Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
    Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    Wezyk M; Szybinska A; Wojsiat J; Szczerba M; Day K; Ronnholm H; Kele M; Berdynski M; Peplonska B; Fichna JP; Ilkowski J; Styczynska M; Barczak A; Zboch M; Filipek-Gliszczynska A; Bojakowski K; Skrzypczak M; Ginalski K; Kabza M; Makalowska I; Barcikowska-Kotowicz M; Wojda U; Falk A; Zekanowski C
    J Alzheimers Dis; 2018; 62(1):175-202. PubMed ID: 29439343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double Mutations in a Patient with Early-Onset Alzheimer's Disease in Korea: An
    Bae H; Shim KH; Yoo J; Yang YS; An SSA; Kang MJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
    Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
    Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
    Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a non-demented family member bearing wild-type PSEN1.
    Muñoz SS; Balez R; Castro Cabral-da-Silva ME; Berg T; Engel M; Bax M; Do-Ha D; Stevens CH; Greenough M; Bush A; Ooi L
    Stem Cell Res; 2018 Aug; 31():227-230. PubMed ID: 30138848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking.
    Montesinos J; Pera M; Larrea D; Guardia-Laguarta C; Agrawal RR; Velasco KR; Yun TD; Stavrovskaya IG; Xu Y; Koo SY; Snead AM; Sproul AA; Area-Gomez E
    EMBO J; 2020 Oct; 39(20):e103791. PubMed ID: 32865299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease-related peptide PS2V plays ancient, conserved roles in suppression of the unfolded protein response under hypoxia and stimulation of γ-secretase activity.
    Moussavi Nik SH; Newman M; Wilson L; Ebrahimie E; Wells S; Musgrave I; Verdile G; Martins RN; Lardelli M
    Hum Mol Genet; 2015 Jul; 24(13):3662-78. PubMed ID: 25814654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the Third Case of PSEN1 Tyr389His Variant in Early-Onset Alzheimer's Disease in Korea.
    Shim KH; Kang S; An SSA; Kang MJ
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
    Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated presenilin-1 endoproteolysis enhances store-operated calcium currents in neuronal cells.
    Ryazantseva M; Skobeleva K; Glushankova L; Kaznacheyeva E
    J Neurochem; 2016 Mar; 136(5):1085-95. PubMed ID: 26678016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
    Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
    Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
    Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling familial Alzheimer's disease with induced pluripotent stem cells.
    Yagi T; Ito D; Okada Y; Akamatsu W; Nihei Y; Yoshizaki T; Yamanaka S; Okano H; Suzuki N
    Hum Mol Genet; 2011 Dec; 20(23):4530-9. PubMed ID: 21900357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
    Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
    Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.